Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation.
- DOI
- 10.3389/fonc.2026.1919279
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1919279,
title = {Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation.},
author = {Bazan Russo TD and Gristina V and Delcuratolo MD and Tamburi L and Delli Muti F and Mangiacotti F and Mujacic C and Fanale D and Galvano A and Gori S and Incorvaia L and Giordano A and Pepe F and Malapelle U and Russo A and Muscarella LA and Fabrizio FP},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1919279},
url = {https://doi.org/10.3389/fonc.2026.1919279}
}RIS
TY - JOUR TI - Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation. AU - Bazan Russo TD AU - Gristina V AU - Delcuratolo MD AU - Tamburi L AU - Delli Muti F AU - Mangiacotti F AU - Mujacic C AU - Fanale D AU - Galvano A AU - Gori S AU - Incorvaia L AU - Giordano A AU - Pepe F AU - Malapelle U AU - Russo A AU - Muscarella LA AU - Fabrizio FP PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1919279 UR - https://doi.org/10.3389/fonc.2026.1919279 ER -
APA
TD, B. R., V, G., MD, D., L, T., F, D. M., F, M., C, M., D, F., A, G., S, G., L, I., A, G., F, P., U, M., A, R., LA, M., & FP, F. (2026). Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1919279
Source records
- pubmed · retrieved 2026-09-26T03:09:25.540Z